BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 12719233)

  • 21. The HERG K+ channel: progress in understanding the molecular basis of its unusual gating kinetics.
    Vandenberg JI; Torres AM; Campbell TJ; Kuchel PW
    Eur Biophys J; 2004 Apr; 33(2):89-97. PubMed ID: 13680209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of amino-terminal distal and proximal domains in the regulation of human erg K(+) channel gating.
    Viloria CG; Barros F; Giráldez T; Gómez-Varela D; de la Peña P
    Biophys J; 2000 Jul; 79(1):231-46. PubMed ID: 10866950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of outer mouth mutations on hERG channel function: a comparison with similar mutations in the Shaker channel.
    Fan JS; Jiang M; Dun W; McDonald TV; Tseng GN
    Biophys J; 1999 Jun; 76(6):3128-40. PubMed ID: 10354437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use-dependent 'agonist' effect of azimilide on the HERG channel.
    Jiang M; Dun W; Fan JS; Tseng GN
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1324-36. PubMed ID: 10565858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transfer of rapid inactivation and sensitivity to the class III antiarrhythmic drug E-4031 from HERG to M-eag channels.
    Herzberg IM; Trudeau MC; Robertson GA
    J Physiol; 1998 Aug; 511 ( Pt 1)(Pt 1):3-14. PubMed ID: 9679158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific block of cloned Herg channels by clofilium and its tertiary analog LY97241.
    Suessbrich H; Schönherr R; Heinemann SH; Lang F; Busch AE
    FEBS Lett; 1997 Sep; 414(2):435-8. PubMed ID: 9315735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deletion of protein kinase A phosphorylation sites in the HERG potassium channel inhibits activation shift by protein kinase A.
    Thomas D; Zhang W; Karle CA; Kathöfer S; Schöls W; Kübler W; Kiehn J
    J Biol Chem; 1999 Sep; 274(39):27457-62. PubMed ID: 10488078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A radiolabeled peptide ligand of the hERG channel, [125I]-BeKm-1.
    Angelo K; Korolkova YV; Grunnet M; Grishin EV; Pluzhnikov KA; Klaerke DA; Knaus HG; Møller M; Olesen SP
    Pflugers Arch; 2003 Oct; 447(1):55-63. PubMed ID: 12905030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular determinants of voltage-dependent human ether-a-go-go related gene (HERG) K+ channel block.
    Sánchez-Chapula JA; Navarro-Polanco RA; Culberson C; Chen J; Sanguinetti MC
    J Biol Chem; 2002 Jun; 277(26):23587-95. PubMed ID: 11960982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. I(Kr): the hERG channel.
    Tseng GN
    J Mol Cell Cardiol; 2001 May; 33(5):835-49. PubMed ID: 11343409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockade of the HERG human cardiac K(+) channel by the antidepressant drug amitriptyline.
    Jo SH; Youm JB; Lee CO; Earm YE; Ho WK
    Br J Pharmacol; 2000 Apr; 129(7):1474-80. PubMed ID: 10742304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes.
    Suessbrich H; Schönherr R; Heinemann SH; Attali B; Lang F; Busch AE
    Br J Pharmacol; 1997 Mar; 120(5):968-74. PubMed ID: 9138706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HERG K+ channels: friend and foe.
    Vandenberg JI; Walker BD; Campbell TJ
    Trends Pharmacol Sci; 2001 May; 22(5):240-6. PubMed ID: 11339975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein kinase A-mediated phosphorylation of HERG potassium channels in a human cell line.
    Wei Z; Thomas D; Karle CA; Kathöfer S; Schenkel J; Kreye VA; Ficker E; Wible BA; Kiehn J
    Chin Med J (Engl); 2002 May; 115(5):668-76. PubMed ID: 12133532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BmTx3, a scorpion toxin with two putative functional faces separately active on A-type K+ and HERG currents.
    Huys I; Xu CQ; Wang CZ; Vacher H; Martin-Eauclaire MF; Chi CW; Tytgat J
    Biochem J; 2004 Mar; 378(Pt 3):745-52. PubMed ID: 14599291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mapping the receptor site for ergtoxin, a specific blocker of ERG channels.
    Pardo-López L; García-Valdés J; Gurrola GB; Robertson GA; Possani LD
    FEBS Lett; 2002 Jan; 510(1-2):45-9. PubMed ID: 11755529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA interference reveals that endogenous Xenopus MinK-related peptides govern mammalian K+ channel function in oocyte expression studies.
    Anantharam A; Lewis A; Panaghie G; Gordon E; McCrossan ZA; Lerner DJ; Abbott GW
    J Biol Chem; 2003 Apr; 278(14):11739-45. PubMed ID: 12529362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inactivation gating determines nicotine blockade of human HERG channels.
    Wang HZ; Shi H; Liao SJ; Wang Z
    Am J Physiol; 1999 Sep; 277(3):H1081-8. PubMed ID: 10484431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetic modulation of HERG potassium channels by the volatile anesthetic halothane.
    Li J; Correa AM
    Anesthesiology; 2002 Oct; 97(4):921-30. PubMed ID: 12357160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of S818L mutation in HERG C-terminus in LQT2. Modification of activation-deactivation gating properties.
    Nakajima T; Kurabayashi M; Ohyama Y; Kaneko Y; Furukawa T; Itoh T; Taniguchi Y; Tanaka T; Nakamura Y; Hiraoka M; Nagai R
    FEBS Lett; 2000 Sep; 481(2):197-203. PubMed ID: 10996323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.